Bartlett & Co’s St Jude Medical STJ Stock Holding History

Bartlett & Co’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-700	Closed	-$56K	–	728
2016 Q4	$56K	Hold	700	–	–	﹤0.01%	414
2016 Q3	$56K	Hold	700	–	–	﹤0.01%	421
2016 Q2	$55K	Hold	700	–	–	﹤0.01%	415
2016 Q1	$38K	Hold	700	–	–	﹤0.01%	452
2015 Q4	$43K	Hold	700	–	–	﹤0.01%	436
2015 Q3	$44K	Sell	700 -20	-3%	-$1.43K	﹤0.01%	429
2015 Q2	$53K	Buy	720 +20	+3%	+$1.45K	﹤0.01%	425
2015 Q1	$46K	Hold	700	–	–	﹤0.01%	446
2014 Q4	$46K	Hold	700	–	–	﹤0.01%	439
2014 Q3	$42K	Hold	700	–	–	﹤0.01%	454
2014 Q2	$48K	Sell	700 -100	-13%	-$6.48K	﹤0.01%	448
2014 Q1	$52K	Hold	800	–	–	﹤0.01%	423
2013 Q4	$50K	Sell	800 -300	-27%	-$17.4K	﹤0.01%	402
2013 Q3	$59K	Hold	1,100	–	–	﹤0.01%	380
2013 Q2	$50K	Buy	+1,100	New	+$47.7K	﹤0.01%	394

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Bartlett & Co's STJ Position: Q1 2017 in Review

Bartlett & Co sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 700 shares — an estimated $56K sold.

Bartlett & Co first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $59K in Q3 2013. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Bartlett & Co reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Bartlett & Co sold 700 St Jude Medical shares in Q1 2017, an estimated $56K.
Bartlett & Co first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
Bartlett & Co's St Jude Medical position peaked at $59K in Q3 2013.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Bartlett & Co's 13F filing for Q1 2017, filed 25 Apr 2017.